AFC-HD AMS Life Science Co., Ltd.

2927

JP3124700000

Food Processing

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
843 ^JPY	+0.48%		-0.35%	+5.38%

2023	Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024	CI
2023	AFC-HD AMS Life Science Co., Ltd. agreed to acquire Clarize Co., Ltd. from Toshiaki Fujita for ¥1	CI

Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024

April 15, 2024 at 02:00 am EDT

AFC-HD AMS Life Science Co., Ltd. announced a dividend of JPY 15 per share for the second quarter ended February 2024 against JPY 12.50 per share paid a year ago. The dividend is payable on May 17, 2024.

Latest news about AFC-HD AMS Life Science Co., Ltd.

Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024	23-10-13	CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire Clarize Co., Ltd. from Toshiaki Fujita for ¥1	23-10-01	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	23-07-14	CI
Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on May 26, 2023.	23-06-27	CI
AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback announced on May 26, 2023, has closed with 100,000 shares, representing 0.71% for Â¥79.57 million.	23-06-26	CI
AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.	23-05-26	CI
AFC-HD AMS Life Science Co., Ltd. authorizes a Buyback Plan.	23-05-25	CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023	23-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023	23-01-13	CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire a 51% stake in 5SPRO Joint Stock Company.	22-12-11	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023	22-10-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending August 31, 2022	22-07-15	CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022	22-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2022	22-01-14	CI
Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on October 27, 2021.	21-12-22	CI
AFC-HD AMS Life Science Co., Ltd's Equity Buyback announced on October 27, 2021, has closed with 300,000 shares, representing 2.11% for ¥289.44 million.	21-12-20	CI
AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 300,000 shares, representing 2.11% for ¥300 million.	21-10-26	CI
AFC-HD AMS Life Science Co., Ltd. authorizes a Buyback Plan.	21-10-26	CI
AFC-HD AMS Life Science Co., Ltd. Reports Consolidated Earnings Results for the Third Quarter Ended May 2021	21-07-12	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 2021	21-07-12	CI
Saikaya Department Store Co.,Ltd. announced that it has received ¥500.955 million in funding from AFC-HD AMS Life Science Co., Ltd.	21-05-25	CI
Saikaya Department Store Co.,Ltd. announced that it expects to receive ¥500.955 million in funding from AFC-HD AMS Life Science Co., Ltd.	21-04-15	CI
AFC-HD AMS Life Science Co., Ltd. entered into a basic agreement to acquire 80.2% stake in Nasubi, K.K. from Keisuke Fujita, Hisanori Fujita and others.	21-04-13	CI
AFC-HD AMS Life Science Co., Ltd. Reports Consolidated Earnings Results for the Second Quarter Ended February 2021	21-04-05	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2021	21-04-05	CI

Chart AFC-HD AMS Life Science Co., Ltd.

Duration

Period

More charts

Company Profile

AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.

Sector

Food Processing

Calendar

2024-07-10 - Q3 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
AFC-HD AMS LIFE SCIENCE CO., LTD.	+5.38%	76.57M
ZHEJIANG NHU COMPANY LTD.	+13.21%	8.15B
BELLRING BRANDS, INC.	+3.16%	7.49B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+12.30%	6.65B
BYHEALTH CO., LTD	-6.99%	3.72B
THE SIMPLY GOOD FOODS COMPANY	-5.71%	3.7B
XIAMEN KINGDOMWAY GROUP COMPANY	-4.78%	1.31B
SIRIO PHARMA CO., LTD.	+12.61%	972M
HERBALIFE LTD.	-37.22%	938M
USANA HEALTH SCIENCES, INC.	-15.02%	906M

Special Foods & Wellbeing Products